U.S. market Closed. Opens in 12 hours

CYT | Cyteir Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/A8.00K
Cost of Revenue1.38M479.00K351.00K12.69K
Gross Profit-1.38M-479.00K-351.00K-4.69K
Operating Expenses48.17M42.26M20.94M16.11M
Selling, General & Admin13.55M11.30M4.18M3.35M
Research & Development34.62M30.96M16.77M12.77M
Other Operating Expenses2.11M133.00K120.00K-8.00K
Operating Income-48.17M-42.26M-20.94M-16.11M
Other Expenses / Income2.11M133.00K120.00K1.06M
Before Tax Income-46.06M-42.13M-20.82M-15.04M
Income Tax Expenses-2.11M-479.00KN/AN/A
Net Income-43.95M-41.65M-20.82M-15.04M
Interest Expenses-668.00KN/AN/AN/A
Basic Shares Outstanding35.27M19.50M23.89M19.43M
Diluted Shares Outstanding35.27M19.50M23.89M19.43M
EBITDA-48.17M-42.26M-20.59M-15.89M
EBITDA Margin0.00%0.00%0.00%-198,625.00%
EBIT-46.73M-42.13M-20.82M-15.04M
EBIT Margin0.00%0.00%0.00%-188,050.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙